We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Vertex Announces Results from Phase 2a Trial of VX-809

News   Feb 05, 2010

 
Vertex Announces Results from Phase 2a Trial of VX-809
 
 
 

RELATED ARTICLES

It's Time to Keep Check on the Microbiome

News

Scientists have developed a novel technique based on an oscillating gene circuit that they hope will help to shed light on the human microbiome.

READ MORE

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

Improving Nature’s Own Ability To Kill Dangerous Bacteria

News

The ramifications of bacteria's ability to become resistant to antibiotics can be seen in hospitals, public places, our food supply, and our water. Now, researchers have demonstrated how we could improve upon the ability of nature's exquisitely selective collection of antimicrobial enzymes to attack bacteria in a way that's much less likely to cause bacterial resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE